| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/05/2002 | US20020183255 Use of KPV tripeptide for dermatological disorders |
| 12/05/2002 | US20020183254 For inhibiting blood coagulation |
| 12/05/2002 | US20020183253 Effecting an increase in the amount of an endostatin in ocular tissues of an individual afflicted with ocular neovascularization to an ocular neovascularization inhibiting effective amount |
| 12/05/2002 | US20020183251 For use as vaccines, and other drugs for the diagnosis and therapy of prostate cancer |
| 12/05/2002 | US20020183250 For use in therapy of sleep disorders |
| 12/05/2002 | US20020183247 Lipoparticle comprising a protein and methods of making and using the same |
| 12/05/2002 | US20020182728 Method for transdifferentiation of non pancreatic stem cells to the pancreatic differentiation pathway |
| 12/05/2002 | US20020182726 Calcium-independent negative regulation by CD81 of receptor signalling |
| 12/05/2002 | US20020182725 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 12/05/2002 | US20020182723 Generation of genetically engineered viral vectors; obtain cells, infect with genetically engineered vector, propagate and harvest viral vectors |
| 12/05/2002 | US20020182708 Nucleotide sequence coding controlling polypeptide for use in the prevention of fungal infections |
| 12/05/2002 | US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins |
| 12/05/2002 | US20020182705 Method for increasing the serum half-life of a biologically active molecule |
| 12/05/2002 | US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 12/05/2002 | US20020182698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 12/05/2002 | US20020182694 Polypeptide for use in the treatment of tumors, autoimmune and degenerative disorders |
| 12/05/2002 | US20020182693 Polypeptide having larvae growth inhibiting or insecticidal effect on scarabaeidae insects and polynucleotide encoding the same |
| 12/05/2002 | US20020182691 Nucleotide sequences coding transport protein for use in nervous system disorders |
| 12/05/2002 | US20020182687 Generation of adaptor nucleotide sequence particles; obtain nucleotide sequences, incubate with adaptor, join, recover adaptor nucleotide sequences |
| 12/05/2002 | US20020182685 In vivo generation of antibodies against antigens secreted in a host by transfected MEL cells |
| 12/05/2002 | US20020182684 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders |
| 12/05/2002 | US20020182683 Vascular endothelial growth factor 2 |
| 12/05/2002 | US20020182680 Method for preparing human serum albumin containing heat-treatment |
| 12/05/2002 | US20020182678 CD29 pig protein, nucleic acid coding for said protein, and applications thereof |
| 12/05/2002 | US20020182677 Nucleotide sequences coding polypeptide for use in the treatment of osteoporosis, paget's, thyroid, pancreatitis, gastrointestinal and pain disorders |
| 12/05/2002 | US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia |
| 12/05/2002 | US20020182675 Novel genes encoding proteins having diagnostic, preventive, therapeutic and other uses |
| 12/05/2002 | US20020182673 Nucleotide sequences coding polypeptide for use in the treatment of degenerative, bone and inflammatory disorders |
| 12/05/2002 | US20020182672 Amplification of preferential polypeptide in bacteria; obtain cells, transform with vector coding preferential polypetide, express vector, recover polypeptide |
| 12/05/2002 | US20020182671 Polypeptide for use in the treatment, diagnosis, and prevention of cell proliferative, autoimmune/inflammatory, neurological and gatrointestinal disorders |
| 12/05/2002 | US20020182670 Modified factor VIII |
| 12/05/2002 | US20020182669 Nucleotide sequences coding glycoprotein for use in the diagnosis and treatment of vision defects |
| 12/05/2002 | US20020182668 Nucleotide sequences coding preferential gene for use in genomic analysis |
| 12/05/2002 | US20020182667 Methods of modulating T lymphocyte costimulation |
| 12/05/2002 | US20020182665 Increased recovery of active proteins |
| 12/05/2002 | US20020182659 Method to determine TGF-beta |
| 12/05/2002 | US20020182655 Method for identifying ligands for G protein-coupled receptors |
| 12/05/2002 | US20020182652 Detection of preferential protein in sample; obtain sample of protein mixture, incubate with probe, detect signal from probes |
| 12/05/2002 | US20020182650 Inhibitors of binding between proteins and macromolecular ligands |
| 12/05/2002 | US20020182639 Synthetic peptides for cartilage resorption assays |
| 12/05/2002 | US20020182638 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020182635 Methods of screening for LTRPC2 modulators |
| 12/05/2002 | US20020182621 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders |
| 12/05/2002 | US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/05/2002 | US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect |
| 12/05/2002 | US20020182605 Determining which of angiotensin receptor 1 (AGTR1) gene halotypes defines one copy of individual's AGTR1 gene wherein each of the AGTR1 haplotypes comprises a set of polymorphisms |
| 12/05/2002 | US20020182596 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 12/05/2002 | US20020182593 Strawberry vein banding virus (SVBV) promoter |
| 12/05/2002 | US20020182582 Process for preparing agents containing virus-inactivated vitamin K-dependent plasma components as well as protein C and protein S by membrane chromatography |
| 12/05/2002 | US20020182228 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins |
| 12/05/2002 | US20020182224 Recombinant fusion protein comprising an amino acid sequence selected from the 27/28 kDa cercarial elastase sequence of S. mansoni fused to a protein selected from suitable bacterial, phage and viral proteins |
| 12/05/2002 | US20020182222 That have "evolved" due to gene shuffling in vitro for inclusion of "cross-clade" characteristics. |
| 12/05/2002 | US20020182221 Recombinant papillomavirus vaccine and method for production and treatment |
| 12/05/2002 | US20020182220 Isolating a heat shock protein 70- peptide complex from the mammal from tumor cells or cells infected with a virus, bacteria or infectious agent; and administering the heat shock protein peptide complex |
| 12/05/2002 | US20020182219 Cancer immunotherapy |
| 12/05/2002 | US20020182218 Therapeutic anti-melanoma compounds |
| 12/05/2002 | US20020182216 Eliciting a T-cell mediated immune response in an animal, comprising administering to the animal an extract of an egg comprising transfer factor generated by said source animal |
| 12/05/2002 | US20020182211 Binds CD80 and/or CD86; an alanine at position +29 is substituted with tyrosine, leucine, tryptophan, or threonine, and a leucine at position +104 is substituted with a glutamic acid |
| 12/05/2002 | US20020182209 Leukemic cell-adsorbing column and adsorbent material therefor |
| 12/05/2002 | US20020182206 Treating an inflammatory disease by administrating a therapeutically effective amount of a PRO301, PRO362 or PRO245 antagonist, or fragment thereof. |
| 12/05/2002 | US20020182200 Use in stem cell mobilization, neuronal protection, and regulating hematopoiesis; inhibiting destruction of hematopoietic progenitor cells resulting from chemotherapy |
| 12/05/2002 | US20020182198 Purified MANF polypeptide (mature astrocyte-derived neurotrophic factor) of given sequence |
| 12/05/2002 | US20020182189 Compositions and methods for the repair and construction of bone and other tissue |
| 12/05/2002 | US20020182182 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 12/05/2002 | US20020182180 Method for inducing immunity to viruses |
| 12/05/2002 | US20020182169 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 12/05/2002 | DE10126164A1 Für das metD-gen kodierende Nukleotidsequenzen For the metD gene coding nucleotide sequences |
| 12/05/2002 | CA2665748A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 12/05/2002 | CA2483254A1 Tumor therapy |
| 12/05/2002 | CA2454557A1 Callus specific plant promoters |
| 12/05/2002 | CA2449127A1 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 12/05/2002 | CA2449056A1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 12/05/2002 | CA2449011A1 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| 12/05/2002 | CA2449004A1 Melanin-concentrating hormone analogs |
| 12/05/2002 | CA2449000A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
| 12/05/2002 | CA2448963A1 Pharmaceutical use for secreted bacterial effector proteins |
| 12/05/2002 | CA2448891A1 Long lasting fusion peptide inhibitors for hiv infection |
| 12/05/2002 | CA2448698A1 Xrcc1 and uses thereof |
| 12/05/2002 | CA2448620A1 Vaccination against the feline immunodeficiency virus |
| 12/05/2002 | CA2448585A1 Method for diagnosing transmissable spongiform encephalopathy |
| 12/05/2002 | CA2448362A1 B7 related protein-2 molecules and uses thereof |
| 12/05/2002 | CA2448348A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/05/2002 | CA2448171A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 12/05/2002 | CA2448148A1 Carbohydrate-associated proteins |
| 12/05/2002 | CA2448146A1 Secreted proteins |
| 12/05/2002 | CA2448116A1 Molecules for disease detection and treatment |
| 12/05/2002 | CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 12/05/2002 | CA2448104A1 Wnv core protein/capsid interacting protein and uses of the same |
| 12/05/2002 | CA2448100A1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 12/05/2002 | CA2447986A1 High affinity ligand for p75 neurotrophin receptor |
| 12/05/2002 | CA2447916A1 Tumor endothelial marker 7.alpha. molecules and uses thereof |
| 12/05/2002 | CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 12/05/2002 | CA2447849A1 Constitutive plant promotor |
| 12/05/2002 | CA2447690A1 Kindling fluorescent proteins and methods for their use |
| 12/05/2002 | CA2447662A1 Transporters and ion channels |
| 12/05/2002 | CA2447629A1 The lectin-like domain of thrombomodulin and its therapeutic use |
| 12/05/2002 | CA2447209A1 Compositions and methods for adipose abundant protein |
| 12/05/2002 | CA2446739A1 Chemokine beta-1 fusion proteins |
| 12/05/2002 | CA2443713A1 Proteins associated with cell growth, differentiation, and death |
| 12/05/2002 | CA2442705A1 Molecules for diagnostics and therapeutics |